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Madison, Wisconsin
We previously demonstrated that exposure of certain human tumor cells to very low chronic doses
of ionizing radiation led to their enhanced survival following exposure to subsequent high doses of
radiation. Survival enhancement due to these adaptive survival responses (ASRs) ranged from
1.5-fold to 2.2-fold in many human tumor cells. Furthermore, we showed that ASRs result from
altered G1 checkpoint regulation, possibly mediated by overexpression of cyclin Dl, proliferating cell
nuclear antigen (PCNA), and the X-ray induction of cyclin A. Because cyclin Dl and PCNA proteins
are components of many DNA synthetic and repair processes in the cell, we tested the hypothesis
that preexposure of cells to low doses of ionizing radiation enabled activation of the DNA repair
machinery needed for survival recovery after high-dose radiation. We examined the role of DNA
break repair in ASRs using murine cells deficient (i.e., severe combined immunodeficiency [SCIDI
cells) or proficient (i.e., parental mouse strain [CB-171 cells) in DNA-dependent protein kinase
catalytic subunit (DNA-PKcs) expression and DNA double-strand break repair. DNA-PKcs is a nuclear
serine/threonine protein kinase that is activated by DNA breaks and plays a key role in double-strand
break repair. DNA-PKcs also phosphorylates several nuclear DNA-binding regulatory transcription
factor proteins (e.g., Spi and p53), which suggests that DNA-PKcs may play a role in regulating
transcription, replication, and recombination as well as DNA repair, after radiation. Therefore, we
exposed confluent SCID or CB-17 cells to low priming doses of ionizing radiation (i.e., 5 cGy) and
compared the survival responses of primed cells to those of unprimed cells after an equitoxic high-
dose challenge. Low-dose-primed SCID or CB-17 cells demonstrated 2-fold enhanced survival after
a high-dose challenge compared to that of unprimed control cells. These data suggest that
expression of the catalytic subunit of DNA-PKcs (expressed in CB-17 not SCID cells) and the
presence of active double-strand break repair processes (active in CB-17, deficient in SCID cells) do
not play a major role in ASRs in mammalian cells. Furthermore, we present data that suggest
that DNA-PKcs plays a role in the regulation of the G2/M cell cycle checkpoint following extremely
high doses of ionizing radiation. - Environ Health Perspect 106(Suppl 1):301-305 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-11301-305odegaard/abstract.html
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Introduction
Adaptive survival responses (ASRs) are agents. ASRs have been observed in many
observed when cells become resistant to cell types, including neoplastic (4) and
cytotoxic agents after previous exposure to normal (5-7) human cells, but the mecha-
low doses of the same (1-4) or different nism(s) underlying the emergence ofsuch
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damage-induced resistance phenotypes
remains obscure.
We recently found that ASRs were
regulated byaltered G1 cell-cycle checkpoint
events occurring at an A point in which the
involvement ofcyclin A was suggested (4).
We discovered that elevated proliferating
cell nuclear antigen (PCNA) and cyclin D1
levels correlated in human cells with the
ability ofthe cell to demonstrate ASRs (4).
The fact that cells primed with low doses
ofionizing radiation appeared to enter the
cell cycle earlier after release by low-cell
density than untreated confluent control
cells confirmed that altered G1 cell-cycle
checkpoint regulation controlled ASRs (4).
Although we demonstrated that such ASRs
were the specific result of new gene tran-
scription and translation, we also demon-
strated that the DNA binding of many
common transcription factors (including
Spl, retinoblastoma control proteins
(RCPs), p53, nuclear factor-KB, egr-1, AP-
1, Oct-1, CREB, GRE, AP-2, and AP-3)
remained unchanged in untreated, primed
(i.e., low-dose irradiated), or high-dose
challenged human cells that demonstrated
highly efficientASRs (8).
After characterizing ASRs in various
human cancer cells after exposure to ioniz-
ing radiation (4,8,9), we decided to use
model cell systems to explore the mecha-
nisms behind ASRs. Since DNA double-
strand break repair is probably the single
most important determinant in radiation
sensitivity, we explored the role of the
DNA-dependent protein kinase catalytic
subunit (DNA-PKcs) in ASRs by compar-
ing severe combined immunodeficiecy
(SCID) cells, which do not express DNA-
PKcs protein, and parental mouse strain
(CB-17) cells, which express normal levels
of the DNA double-strand break repair
component [C-R Yang et al., unpublished
data; (10)]. Our data indicate that DNA-
PKcs plays no role in ASRs since low-dose
ionizing radiation-induced resistance was
apparent in both cell lines. Further cell cycle
analyses using flow cytometry did reveal,
however, that DNA-PKcs plays a role in
G2/M cell-cycle checkpoint responses after
very high-dose ionizing radiation exposures.
Major differences between SCID and CB-
17 cells in the overall number of cells in
G2/M and differences in the length oftime
that damaged cells delayed in G2/M follow-
ing ionizing radiation were observed. These
data suggest a dual role for DNA-PKcs in
repair and cell-cycle regulation.
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Materials and Methods
Celi Culture Conditions
Fibroblast cell lines derived from an SCID
mouse and the corresponding CB-17, from
which SCID mice were derived, were pro-
vided by M. Brown (Stanford University,
Stanford, CA) (10). Both cell lines were
grown in Dulbecco's Modified Eagle's
medium, supplemented with 10% fetal
bovine serum, penicillin 6-k (100 U/ml),
and streptomycin sulfate (50 U/ml) in a
I0/o C02-90% air atmosphere at 37'C.
Analyses of these cell lines indicated that
both express mutant p53 protein (i.e., high
levels of p53 protein were found in the
nucleus of each cell and DNA binding as
measured by DNA band shift analyses was
not observed), both express the retinoblas-
toma protein (pRb), and each cell line
exhibits high levels of unphosphorylated
Ku70-Ku80 heterodimeric DNA end-
binding activity. SCID cells did not express
DNA-PKcs enzyme activity or protein lev-
els (or at least expressed levels that were not
detected by either assay) (C-R Yang et al.,
in preparation).
Cell IAadiaton and Clonogenic
SurvivalAssessments
SCID and CB-17 cells were plated onto
100-mm2 tissue culture dishes and fed
every third day until confluent, with both
sets ofcells obtaining an 85 to 90% arrest
in GO/G1, as determined by flow cytometry
(4,11,12). The cell lines did not varysignif-
icantly in their doubling times or plating
efficiencies, and each cell line demonstrated
approximately 42% efficiency in plating.
Once confluent, low-dose (priming) or
high-dose (challenging) ionizing radiation
exposures were applied using a Phillips
X-ray-generator as described (13,14). For
low-dose priming exposures, cells were
treated with 5 cGy at 24-hr intervals ifmul-
tiple priming doses were used. In a previous
report (4) we demonstrated that a single
priming dose of ionizing radiation was
equivalent to repeated multiple priming
doses. Cells (primed or unprimed) were
also exposed to a high-dose challenge to
yield equitoxic survival (i.e., approximately
10% survival in nonadapted cells). As
expected, we found that SCID cells were
much more sensitive to ionizing radiation
than CB-17 cells. A dose of 250 cGy to
SCID cells was equivalent in terms of
clonogenic survival to a 500-cGy dose to
CB-17 cells. Four hours after exposure cells
were trypsinized, serially diluted in 5-fold
increments, and plated on 60-mm2 tissue
culture dishes for clonogenic survival assess-
ment. After 14 days ofgrowth, cells were
rinsed twice with phosphate-buffered saline
(PBS) and stainedwith a 0.2% crystal violet
solution in methanol. Colony-forming abil-
ity was then scored by counting normal-
appearing colonies (i.e., those containing
100 or more normal-appearing cells) as pre-
viously described by Boothman et al. (14),
with error values indicating the standard
deviation for each group. Experiments were
conducted three times and duplicate cul-
tures from each manipulation were
obtained for each experiment.
FlowCytometry
Cells were treated with or without various
doses of ionizing radiation as described
above. For flow cytometric analyses, cells
were washed twice with ice-cold PBS
(150 mM NaCl, 50 mM KH2PO4, pH
7.4), trypsinized, and washed with a
Tris/saline solution (10 mM Tris [pH 7.0]
and 50 mM NaCI). Cells were then fixed
in 90% ethanol-Tris/saline and stored at
4°C for up to 7 days. Samples were pre-
pared for cell-cycle analyses by washing
once with phosphate-citric acid buffer (0.2
M Na2HPO4 and 0.1 M citric acid [pH
7.8]) and staining with a solution contain-
ing 0.2% NP-40, RNase A (7,000 U/ml),
and 33 pg/ml propidium iodide for 10
min. In our studies the phosphate citric
acid wash has been a critical step for accu-
rate assessment of apoptotic cell popula-
tions (15). Stained nuclei were analyzed
for DNA-propidium fluorescence using a
Becton Dickinson FACScan (Becton
Dickinson, San Jose, CA) at a laser setting
of36 mW and an excitation wavelength of
488 nM. Resulting DNA distributions
were analyzed for the proportion ofcells in
apoptosis and for cells in GO1G,, S, and
G2/M phases ofthe cell cycle. Both SCID
and CB-17 cells were 100% diploid at the
beginning and end ofeach experiment, and
in each case over 7000 events or cells were
modeled using the program Modfit (Verity
Software House, Topsham, ME). To visu-
alize alterations in cell-cycle distributions,
supralethal doses ofionizing radiation (i.e.,
10-15 Gy) were used. Experiments were
conducted three times and duplicate cul-
tures from each manipulation were obtained
in each experiment.
Results
SurvivalAssessments
When treated with low priming doses of
ionizing radiation (5 cGy), both SCID and
CB-17 cells demonstrated greater survival
(125 ± 9% and 137 ± 15%, respectively)
than those in unirradiated cultures (Table
1). This increase in colony-forming ability
was highly reproducible in these two cell
lines and has been observed with all cell
lines that subsequently demonstrate ASRs
to ionizing radiation (4,8,9). The plating
efficiencies (-42%) and growth rates of
each unirradiated cell line wereverysimilar.
Both SCID and CB-17 cells also
demonstrated efficient ASRs following to
either one or two low-dose priming expo-
sures of ionizing radiation. As expected,
unprimed SCID or CB-17 cells treatedwith
approximately equitoxic high challenging
doses ofionizing radiation (i.e., 250 cGy for
Table 1. Role of DNA-PKcs expression in adaptive survival responsesa.
% Survival (colony-forming ability)c
CB-17 (expresses SCID (does not
Treatmentb DNA-PKcs) express DNA-PKcs)
Untreated, 0.0 cGy 100 ±5 100± 1
Low-dose primed, 5cGy 137 ± 15 125 ±9
2xprimed, 2x5cGy 58±2 90± 11
Challenged, 250cGySCID; 500cGy CB-17 12 ± 5 9 ± 1
Primed then challenged, 5cGy, 250cGy SCID, 500 cGY CB-17 22 ± 3 21 ± 3
2xprimeddthen challenged, 5cGy, 250 cGySCID, 500 cGY CB-17 20 ± 7 18 ± 6
aSCID cells do not express the DNA-PKcs required for DNA double-strand break repair, whereas CB-17 cells
express the protein and are competent at double-strand break repair. Therefore, SCID cells are deficient in double-
strand break repair and V(D)J rejoining, whereas CB-17 cells are proficient at both. bSCID and CB-17 cells were
grown to confluence arrest using the multiple feeding schedule described in "Materials and Methods," and in
Boothman eta!. (23). Cells were then mock irradiated ortreated with low-dose priming exposures of ionizing radi-
ation (i.e., 5 cGy) or high-dose challenging exposures (i.e., 250 cGy for SCID, 500 cGy for CB-17). cColony-forming
ability was measured using the trypsinization-serial dilution method as described in Boothman et al. (14). Only
colonieswith 100 or more normal-appearing cells were scored as a viable colony and presumed to be clonal. dDual
priming doses of ionizing radiation (i.e., 2x5 cGy) were used to compare the effects with single-primed cells.
Single priming was as efficient at producing ASRs as the multiple priming dose of ionizing radiation described in
previous reports (4,9).
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SCID, 500 cGy for CB-17) demonstrated
similar surviving fractions (approximately
9-12% survival) (Table 1). Exposure ofCB-
17 cells to a high-dose challenge ofirradia-
tion resulted in 12 ± 5% survival. CB-17
cells demonstrated a nearly 2-fold increase
in survival (i.e., 22% ±3%) after exposure to
5 cGy priming and a subsequent high-dose
challenge (Table 1). Interestingly, CB-17
cells exposed to two priming doses followed
by a high-dose challenge also demonstrated
a 2-fold increase in survival (20% ±7%)
compared to cells receiving only a high-dose
challenge. It is not clear why CB-17 cells
demonstrated low survival following two
priming doses ofionizing radiation alone
(58 ±2%), yet still demonstrated efficient
ASRs (Table 1).
SCID cells treated with a high dose of
equitoxic, ionizing irradiation (250 cGy)
showed similar survival levels (i.e., 9 ± 1%)
to those demonstrated for CB-17 cells
(Table 1). SCID cells exposed to one
priming dose (5 cGy) followed by a high-
dose challenge of ionizing radiation
showed 21 ±3% survival. Cells receiving
two priming doses followed by a high-dose
challenge showed 18% ±6% survival, indi-
cating that as with CB-17 cells one prim-
ing dose of ionizing radiation was
equivalent to multiple doses of radiation
in terms ofestablishing ASRs. Unlike CB-
17 cells, SCID cells demonstrated only a
slight decrease in survival (i.e., 90 ± 11%)
after two priming doses (Table 1).
To investigate the possibility that ASRs
were the result of altered cell-cycle distri-
bution or cell viability between cell types
[other than minor fluctuations in the
GO/G, portion of the cell cycle as previ-
ously described (4)], we analyzed cell-cycle
population differences in primed or
unprimed confluent SCID or CB-17 cells
4 to 30 hr after a high-dose challenge of
ionizing radiation (250 cGy for SCID, 500
cGy for CB-17). Analyses of multiple
experiments in which confluence-arrested
SCID or CB-17 cells were treated with var-
ious doses ofionizing radiation revealed no
measurable differences between unirradi-
ated and irradiated cells (regardless ofdose)
in the cell cycle (i.e., cells in GO/G1, S,
G2/M, and the overall percentage of
apoptotic cells) when cells were maintained
in confluence arrest (data not shown). Both
unirradiated and irradiated populations
(24 hr posttreatment) were 90% in GO/G,
under the conditions ofour experiments.
We are currently examining longer time
points after radiation to ascertain if more
dramatic cell-cycle changes occur; however,
results similar to those described here were
previously published (4,9).
RoleofDNA-PKcs inCell-cyde
RegulationafterIonizingRadiaton
In an attempt to determine the effect of
DNA-PKcs expression (and therefore the
presence or absence ofdouble-strand break
repair) on cell cycle regulation after ionizing
radiation exposure, log-phase SCID and
CB-17 cells were treated with various doses
ofX-rays; samples were taken at 4, 16, and
28 hr. Changes in cell-cycle distribution
were then monitored by flow cytometry, as
described in "Materials and Methods." The
data in Figure IA to E (for CB-17) and
Figure 2A to E (for SCID) indicate that
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Figure 1. Cell cycle regulation in CB-17 mouse cells, which express normal levels of the DNA-dependent DNA-PKcs after various doses of ionizing radiation. Log-phase CB-17
mouse cells, which express normal levels of DNA-PKcs, were plated at low densities. Twenty-four hours later, cells were irradiated with various doses of ionizing radiation
and allowed to grow. Changes in cell-cycle distribution were monitored using flow cytometry as described in "Materials and Methods." Doses of ionizing radiation to which
CB-17 cells were exposed were as follows: (A) 0.0 Gy; (B) 2.5 Gy; (C) 5.0 Gy; (D) 10 Gy; and (E) 15 Gy (1 Gy is equivalent to 100 cGy, the units used in the text). At certain data
points, error bars were smaller than the symbol used.
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Figure 2. Cell cycle regulation in SCID mouse cells, which lack expression of the DNA-PKcs, after various doses of ionizing radiation. Log-phase SCID mouse cells, which lack
the expression of DNA-PKcs, were plated at low densities. Twenty-four hours after plating, cells were irradiated with various doses of ionizing radiation and allowed to grow.
Cell cycle distribution effects were monitored using flow cytometry as described in "Materials and Methods." Doses of ionizing radiation to which the SCID cells were
exposed as follows: (A) 0.0 Gy, (B) 2.5 Gy; (C) 5.0 Gy; (D) 10 Gy; and (E) 15 Gy (1 Gy is equivalent to 100 cGy, the units used in the text). At certain data points, error bars
were smaller than the symbol used.
SCID cells (which lack DNA-PKcs expres-
sion) arrest only transiently in G2/M after
ionizing radiation, particularly at higher
doses (> 1000 cGy) ofionizing radiation. In
contrast CB-17 cells (which express normal
levels ofDNA-PKcs) demonstrated efficient
(> 60%) and a more prolonged (> 30 hr)
G2/M cell-cycle checkpoint, particularly at
the higher doses (> 1000 cGy) of ionizing
radiation. No apparent GO/G, arrest was
observed in CB-17 cells (Figure ID, 1E) at
the higher doses ofirradiation as observed in
SCID cells (Figure 2D, 2E), probably
because ofthe rather potent G2/M cell cycle
arrest and because both cell lines express
mutant p53 levels. These data are consistent
with the lack ofG, cell-cycle checkpoint
function of mutant p53 in various human
and rodent cells (16-18). The S phase pop-
ulation of both cell types was reduced at
these higher doses of radiation (Figure 1D,
1E and Figure 2D, 2E) consistent with cell-
cycle progression and subsequent arrest
at G2/M. These data indicate not only that
the expression of DNA-PKcs is involved in
double-strand break repair, but that DNA
break repair may play a role in the G2/M
cell-cycle checkpoint. Although there were
only slight changes in apoptosis within and
between cell lines, additional experiments
currently are being performed to examine
later time points that may indicate a role for
DNA-PKcs in the regulation ofapoptosis.
Discussion
Our data demonstrate that the DNA
double-strand break repair protein, DNA-
PKcs, does not play a major role in adap-
tive survival responses in mammalian cells.
SCID cells, which lack expression of
DNA-PKcs [(10,19,20); Yang et al., in
preparation], demonstrated efficient and
pronounced (2-fold) ASR-mediated
increased resistance to ionizing radiation
due to prior 5 cGy priming. Our data
demonstrate that a single low dose ofioniz-
ing radiation can induce ASRs in mouse
cells and that multiple priming doses are
not necessarily required. These data are
consistent with our previous results (4,9).
Although DNA-PKcs does not play a
role in ASRs, it may play a role in the
G2/M cell-cycle checkpoint similar to the
recently described role ofthe human mutL
homologue protein in this cell-cycle check-
point (21). Data in Figures 1 and 2
demonstrate that genetically matched, irra-
diated cells (i.e., CB-17 cells that express
DNA-PKcs and SCID cells that lack this
protein) differ significantly in the extent
and length of time spent in the G2/M
checkpoint following very high doses of
ionizing radiation (i.e., 10 Gy). Only a
small proportion of SCID cells demon-
strated a very transient G2/M cell-cycle
arrest, whereas a much larger proportion of
CB-17 cells appeared to delay much longer
at this cell-cycle checkpoint. Assuming that
SCID and CB-17 cells received the same
initial DNA damage (10,19), (i.e., cells
were treated with equitoxic doses ofX rays),
the difference in cell-cycle regulation at this
checkpoint could be a major determinant
in overall cell sensitivity to ionizing radia-
tion. The persistent presence ofDNA dou-
ble-strand breaks and the lack ofcell-cycle
blockage at the G2/M cell-cycle checkpoint
before chromosome segregation would be
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disastrous to cell viability in SCID cells. It
should be noted, however, that this phe-
nomenon was only observed at very high
doses of ionizing radiation. Later time
points may be needed to observe difference
among these cells at lower doses.
According to conventional theory, the
presence ofdouble-strand breaks is thought
to lead to G2/M cell-cycle checkpoint arrest.
In the case ofSCID cells, however, the data
indicate the possible existence of DNA
double-strand break tolerance that would be
sufficient to explain the dramatic decrease in
cell survival ofthese cells compared to that
for their genetically matched partner, CB-17
cells. Our data indicate the possibility ofa
prominent role for DNA-PKcs in the G2/M
cell-cycle checkpoint, which may exist to
allow repair before mitotic segregation.
Further experimentation is under way
to explore links between DNA-PKcs, its
absence, and/or apoptosis. We speculate
that SCID cells may be similar to preapop-
totic cells, in which DNA-PKcs is cleaved
by radiation- or DNA damage-induced
apoptotic proteases (22). The lackofexpres-
sion of DNA-PKcs in SCID cells may,
therefore, predispose the cell for commit-
ment to undergo an apoptotic death.
Therefore, DNA-PKcs may not only be
involved in double-strand break repair and
cell-cycle regulation; it actually may be a
pivotal player as an apoptotic protector
against programmed cell-death responses
that occurafter ionizing radiation.
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